GlassScriptPhysician profile
Jonathan I Cohen
NPI 1619077690
$1,077.22
in general payments reported to CMS, 2019-2025
11 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $177 · 2021: $18.27 · 2022: $41.71 · 2023: $305 · 2024: $60.50 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.38 | 2019-2022 | |
| Glaxosmithkline, LLC. | $139.67 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $113.22 | 2023 | Lifevest |
| Olympus America INC. | $109.12 | 2025 | |
| Pfizer INC. | $59.39 | 2024-2025 | |
| Novo Nordisk INC | $49.60 | 2023-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $29.08 | 2022-2023 | Nuedexta |
| Capsovision, INC. | $20.22 | 2023 | Capsocam Plus |
| Zimmer Biomet Holdings, INC. | $18.27 | 2021 | |
| Merck Sharp & Dohme LLC | $17.31 | 2025 | Capvaxive |
| Ultragenyx Pharmaceutical INC. | $14.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.